Condition: Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) · Sponsor: Nanjing RegeneCore Biotech Co., Ltd.
This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy and safety of RC1416 injection in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
This description comes directly from the study's public registry record.
Yumin Zhou, MD · +86-13826190798 · zhouyumin410@126.com
Always discuss trial participation with your own doctor first.
| Anhui Provincial Chest Hospital | Hefei, Anhui, China | Recruiting |
| Wan Bei General Hospital of Wanbei Coal power Group | Suzhou, Anhui, China | Recruiting |
| The Affiliated Bishan Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Recruiting |
| Zhongshan Hospital Xiamen University | Xiamen, Fujian, China | Recruiting |
| The first affiliated hospital of guangzhou medical university | Guangzhou, Guangdong, China | Recruiting |
| The First Affiliated Hospital of Jinan University | Guangzhou, Guangdong, China | Recruiting |
| The first affiliated hospital of guangzhou medical university | Guangzhou, Guangdong, China | Recruiting |
| Huizhou Third People's Hospital | Huizhou, Guangdong, China | Recruiting |
| Jiangmen Central Hospital | Jiangmen, Guangdong, China | Recruiting |
| Guangzhou Medical University Affiliated Qingyuan Hospital (Qingyuan People's Hospital) | Qingyuan, Guangdong, China | Recruiting |
| The First Affiliated Hospital of guangxi Medical University | Nanning, Guangxi, China | Recruiting |
| The First People's Hospital of Yulin | Yulin, Guangxi, China | Recruiting |
+ 30 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07402551